SARASOTA, Fla., March 7 , 2016 /Weed Wire/— 420 Ventures announces today that it has acquired majority stake in Le Herbe and the United Hemp Company.
Tag Archives: CBD
A Florida medical marijuana bill is heading back to the floor of the state Senate. According to the Associated Press, the bill, Senate Bill 460, had been referred to the rules committee after a number of last minute amendments were requested.
As cannabis becomes increasingly welcomed in the United States, an exciting variety of companies are continuing to enter the space.
DENVER, Feb 25, 2016 /Weed Wire/ — Juju Royal has announced the addition of industry veteran Derek Collins, CEO of BD Labs, as the operating company that is licensing the Juju Royal brand THC and CBD vape pens.
FORT WORTH, Texas, Feb. 22, 2016 /Weed Wire/ — The Southwest Cannabis Conference & Expo is pleased to announce special celebrity keynote speaker Montel Williams for the largest Texas cannabis conference in history.
RICHMOND, Va., Feb. 17, 2016 /Weed Wire/ — Yesterday, the Virginia Senate by a vote of 37 to 2 passed SB701,a bill that would allow the production and manufacturing of Cannabidiol (CBD) oil and THC-A oil in the state.
Weekly CannaBit for the week of Feb. 1, 2016: Currently, half of the American population lives in a state where medical marijuana is legal and one-third (35%) live in a CBD-only state. Four states will vote on medical marijuana legalization in 2016.
VANCOUVER, British Columbia, Feb. 3, 2016 /Weed Wire/ — Wildflower Marijuana Inc. (CSE: SUN) (FWB:RSP) (the “Company”) announces that it has reached a major milestone by becoming Canada’s first cannabis company to launch a line of products into the legal US cannabis market.
KELOWNA, British Columbia, Jan. 20, 2016 /Weed Wire/ — Lexaria Corp. is very pleased to announce study data from human subjects demonstrating significant elevation of systemic nitric oxide levels.
LOS ANGELES, Jan. 12, 2016 /Weed Wire/ —GreenTech Industries, a specialty business company with interests in the cannabis and entertainment industries, announced today that it has organized its corporate structure as a holding company, complete with its initial line-up of branded products in its company portfolio.
On Dec. 29, 2015, Georgia Sen. Harold Jones II pre-filed legislation that would eliminate felony marijuana possession in the state.
On New Year’s Day, a small group of protestors staged a demonstration on the steps of Idaho’s Capitol building in Boise, ending in one citation. Leading the protest was Serra Frank, founder of the advocacy group Moms for Marijuana International.
Georgia Rep. Allen Peake has announced his plans to reintroduce a bill into the legislature that would allow CBD-only marijuana to be grown in the state for medicinal purposes.
Right before Christmas, on Dec. 23, 2015, the DEA released a press release quietly announcing a new federal advancement on cannabinoid research.
The rollout of Florida’s limited, CBD-only, medical marijuana program has been fraught with legal delays and now the process stands to take even longer.
In Georgia on Dec. 9, 2o15, a blue ribbon panel appointed by Gov. Nathan Deal rejected a proposal to expand the state’s limited medical marijuana program.
GW Pharma is reportedly ramping up production of Epidiolex in anticipation of FDA approval and the significant commercial demand for the drug that would follow.
While the debate over the efficacy of medical marijuana continues, there is a growing body of evidence that suggests it may be helpful in treating patients suffering from intractable seizures.
Before the medical community can truly nail down consistent and proper dosage directed at relieving specific symptoms, there needs to be a revolution in the way the entire industry collects and analyzes data.
There are a variety of new THC-infused “Wake & Bake” coffee and tea products emerging onto the marijuana marketplace.
The acceptance of medical marijuana as a legitimate drug has begun to move legalization policy, sometimes quite dramatically, in a number of states.
Smoking might be the most efficient way to receive the health benefits of cannabis, but it is not necessarily the best option for all consumers.
Zynerba presented the status of its research program at BIO Investor Forum. This is a 14-year-old annual biotech gathering, with roughly 600 attendees from 21 countries, and the presentation, in San Francisco, looked likely to be a big event in this company’s development.
In Idaho, up to 25 children suffering from debilitating seizures will soon be able to enroll in a limited program that will provide them with Epidiolex, an experimental CBD-based drug derived from marijuana.
As the Western Hemisphere heads into fall, a strange thing is starting to happen across the pond. Not one but several companies who manufacture and distribute cannabinoid-processed end products are looking to European expansion.
Because research is relatively underdeveloped in the segment of cannabis for pet health, there is ample opportunity for companies to find a strong foothold and ultimately stake claim to this market.
Lexaria Corp. (OTCQB: LXRP) is a food sciences company focused on the delivery of CBD through gourmet foods. Lexaria owns two patent-pendings for delivery of CBD or THC infused within lipids.
Dixie Brands Inc., in partnership with TBSK LLC, has announced the debut of Therabis, an innovative medical pet supplement containing trace elements of hemp-derived CBD and other natural ingredients.
With recreational marijuana legal in four states and Washington, D.C., and medical marijuana legal in 23 states and the District, it can sometimes be hard to remember that marijuana is still highly illegal in the majority of U.S. states.
Should marijuana be administered to assist with pain relief to help ease suffering during hospice and palliative care?
Lexaria Corp. (OTCQB: LXRP) is not the average marijuana tech-related startup. For one thing, its founders originally began their careers in oil and gas.
While it is a far cry from rolling back prohibition altogether, the legalization wave appears to be crashing upon the beaches of the British Isles this summer. As of July 31, 2015, the branded “Charlotte’s Web” CBD oil went on sale in England after it was legalized last month.
Scientists in Israel continue to establish their work as the leading source of data on medical cannabis. In a combined study conducted primarily by researchers from Hebrew University of Jerusalem and Tel Aviv University, Cannabidiol (CBD) was found to enhance fracture healing.
This year’s annual My Compassion Cannabis Conference in Chicago brought together advocates, vendors and prospective medical marijuana patients during a three-day event focused on education and networking.
When people say “medical marijuana,” they often think of cancer patients, people suffering from PTSD, or persons struggling with chronic pain. There is a huge laundry list of ailments that medical marijuana can purportedly treat, and the newest addition to that list is broken bones.
DELAVAN, Ill., July 17, 2015 /PRNewswire/ — Cultivation operations have begun at Revolution Cannabis –Delavan, an enormous, state of the art facility designed to lead the world in production, research and development of medicines derived from cannabis.
MyDx’s hardware/software ecosystem has a very easy value proposition to dish out: simple, instant testing of solids, liquids and gases to measure their positive attributes, and whether there’s any pesticides or other no-gooders in your food, water and air.
PETACH TIKVA, Israel, June 17, 2015 /PRNewswire/ — OWC Pharmaceutical Research Corp. (OTCQB: OWCP), today announced that its wholly owned subsidiary, One World Cannabis Ltd. (“the Company”), an Israel-based developer of cannabinoid-based therapies targeting a variety of different indications, is proud to announce it has received the first basic science study (lab) results on the effect of several combination of Cannabidiol (CBD) and tetrahydrocannabinol (THC) on multiple myeloma cell line RPMI8226.
A recent decision by the governor of Missouri has received a good deal of national attention because it is one of many signs that things are headed the other way: authorities are calling a truce in the war on drugs or, at the least, they are muzzling the biggest guns.
When the Florida legislature passed a low-THC/high-CBD medical marijuana bill last year, most people expected the system to be set up by now.
Last week, the Florida Department of Health announced it plans to use its earmarked CBD research funds to test Epidiolex, a drug patented and produced by the publicly traded pharmaceutical company, GW Pharma (NASDAQ: GWPH).
In Rhode Island, the currently proposed bill, sponsored by Burrillville Democrat Rep. Cale Keable, would legalize the growth and sale of hemp products.
The Land of Lincoln’s medical marijuana program has been off to a slow start—with not one patient yet receiving treatment from the pilot program that went into effect Jan. 1, 2014.
Cannabis advocates have scored a small but important victory in Texas as the state legislature passed a limited medical cannabis bill, Senate Bill 339, on May 19, 2015.
Cannabis use as a medicinal aid for pets has started to gain traction in the last couple years, going so far as to have entire sections of companies dedicated to the offering.
As a newcomer to the legal cannabis space, the alphabet soup of chemical chemotypes, or distinct chemical compounds, can be overwhelming. These abbreviations should not be dismissed because they indicate the chemical composition of cannabis plants.
The clock for Florida has finally running down, and unless a miracle happens by Friday, it looks like the voters will get the last say on the issue of medical marijuana.
Cannabis’ rich history of geography informs its place in contemporary culture, but more importantly, its geography directly informs its physiological evolution.
The American Academy of Neurology has reported promising results in early trials of the drug, Epidiolex, which is 98 percent pure cannabidiol, in treating severe forms of pediatric epilepsy, including Dravet syndrome and Lennox-Gastaut syndrome.
A medical marijuana bill is on the fast track to move forward in the Florida state legislature. The bill, SB 7066, hopes to fix some of the problematic wording in a 2014 bill, SB 1030, which legalized a low-THC high-CBD strain of medical marijuana called Charlotte’s Web.